Kwality Pharma India

Kwality Pharma India, established in 1983 and trading under BSE: 539997, is a prominent player in the pharmaceutical and healthcare sectors. The company specializes in the manufacturing of complex pharmaceutical molecules, with a strategic focus on generic injectables and oncology medications. Recognized for its stringent adherence to international quality benchmarks, Kwality Pharma India has secured prestigious certifications including EU-GMP and PIC/S, underscoring its commitment to global standards. Its operations are anchored in India, contributing to the nation's robust pharmaceutical export landscape. The company's dedication to quality and innovation drives its mission to provide accessible medical solutions across diverse therapeutic areas.

Operating with a workforce of 500 - 1,000 employees across 4 locations, Kwality Pharma India emphasizes operational excellence and continuous growth. The company is actively developing niche injectable products designed to address critical health challenges. This focus on specialized formulations, coupled with a commitment to economic viability, positions Kwality Pharma India as a key provider of advanced pharmaceutical treatments. Potential partners and stakeholders can learn more about the dedicated professionals driving this innovation by visiting Meet Kwality Pharma India's team. The company's strategic approach integrates advanced manufacturing capabilities with a deep understanding of market needs.

Kwality Pharma India targets significant international markets, including Africa, ASEAN countries, and the Gulf region, aiming to deliver affordable and innovative healthcare solutions. With a reported revenue of $58.4M, the company demonstrates substantial market penetration and financial stability. Its product portfolio, including generic injectables and oncology drugs, directly addresses unmet medical needs. Kwality Pharma India'sView more...